A01K 2267/0368
Animal model for inflammation
A01K2267/0368 (Animal model for inflammation) appears on 157 US grants and 283 published applications in this corpus.
Search patents in A01K- Granted patents
- 157
- Published applications
- 283
- Assignees
- 185
- Inventors
- 613
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 8 | 0 |
| 1999 | 4 | 0 |
| 2000 | 10 | 0 |
| 2001 | 6 | 2 |
| 2002 | 5 | 10 |
| 2003 | 7 | 22 |
| 2004 | 7 | 14 |
| 2005 | 2 | 10 |
| 2006 | 4 | 13 |
| 2007 | 9 | 11 |
| 2008 | 1 | 13 |
| 2009 | 2 | 11 |
| 2010 | 3 | 15 |
| 2011 | 6 | 10 |
| 2012 | 0 | 8 |
| 2013 | 4 | 7 |
| 2014 | 2 | 6 |
| 2015 | 3 | 19 |
| 2016 | 7 | 9 |
| 2017 | 8 | 9 |
| 2018 | 5 | 15 |
| 2019 | 8 | 12 |
| 2020 | 7 | 11 |
| 2021 | 11 | 10 |
| 2022 | 3 | 17 |
| 2023 | 4 | 10 |
| 2024 | 4 | 9 |
| 2025 | 10 | 6 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- IL-15 humanized mouse model and use thereof24 Mar 2026US 12,582,106 B2Gempharmatech Co., Ltd.
- Composition comprising MLS-STAT3 for prevention or treatment of immune disease9 Dec 2025US 12,492,233 B2The Catholic University of Korea Industry-Academic Cooperation Foundation
- Mouse model of DITRA disease and uses thereof18 Nov 2025US 12,471,579 B2Regeneron Pharmaceuticals, Inc.
- Gene editing to improve joint function23 Sep 2025US 12,419,968 B2Orthobio Therapeutics, Inc.
- Methods and compositions for modulating innate lymphoid cell pathogenic effectors2 Sep 2025US 12,402,610 B2Massachusetts Institute of Technology
- Gene Editing to Improve Joint Function27 Aug 2026US 2026/0248955 A1Orthobio Therapeutics, Inc.
- Mouse model of ditra disease and uses thereof7 May 2026US 2026/0123613 A1Regeneron Pharmaceuticals, Inc.
- Zebrafish animal model for inflammatory diseases and method for screeing anti-inflammatory agents using same23 Apr 2026US 2026/0107927 A1Raydel Korea Co., Ltd.
- Compositions and methods utilizing a novel human foxo3 isoform16 Apr 2026US 2026/0102465 A1New York Society for the Relief of the Ruptured and Crippled, maintaining the Hospital for Special S
- Treatment of mst1 related diseases and disorders9 Oct 2025US 2025/0313841 A1Empirico Inc.
Most cited
By later US patents
- Transgenic non-human animals capable of producing heterologous antibodies950US 5,770,429 AGenPharm International, Inc. · 1998
- Compositions and methods for the treatment and diagnosis of immune disorders111US 6,562,343 B1Millennium Pharmaceuticals, Inc. · 2003
- Compositions and methods for the treatment and diagnosis of immune disorders106US 6,414,117 B1Millennium Pharmaceuticals, Inc. · 2002
- Expression of human interleukin-1.beta. in a transgenic animal103US 5,824,837 AMerck & Co., Inc. · 1998
- Mice mutant for functional Fc receptors and method of treating autoimmune diseases90US 5,877,396 ASloan-Kettering Institute for Cancer Research · 1999